10
report
Targeting Tau — Our Hope to Solving the Dementia Crisis
In our systems-based review of the biomedical landscape supporting research of a cellular protein c
alled tau—a common culprit in a number of neurodegenerative diseases—we make the case that focused strategic investment in tau research and the , At present, no disease-modifying therapies for the pure tauopathies exist. Researchers are working to develop effective therapeutic agents, which include approaches such as decreasing the amount of tau within the brain., Symptomatic Interventions
At present, no disease-modifying therapies for the pure tauopathies exist.
+ Read More
report
Advancing Models of Patient Engagement: Patient Organizations as Research and Data Partners
FasterCures, alongside other patient-focused advocacy organizations, has long worked with stakehold
ers such as product developers and regulators to define and implement the “how to” of patient
+ Read More
report
Misophonia - A Giving Smarter Guide
report
Financing Lung Cancer Screening in China
Lung cancer, one of the most preventable diseases, surpasses all other cancer deaths worldwide.
report
New Models for Financing Translational Medical Research in Singapore: Update
Since 2017, the Milken Institute has engaged with stakeholders worldwide on new models for financin
g translational biomedical research in Singapore.
+ Read More
video
Part 1: A Conversation with FDA Commissioner Stephen Hahn | Part 2: Health Innovation: Improving Patient Access and Information
October 21 at 11:45 am PDT/2:45 pm EDT
This session will open with a conversation with St
ephen Hahn, Commissioner, US Food and Drug Administration, followed by a panel discussion.
+ Read More
video
Giving Smarter in the Age of COVID-19.
October 20 at 9:00 am PDT/12:00 pm EDT
video
What Is the Prognosis for COVID-19 Treatments and Vaccines?
October 12 at 7:45 am PDT/10:45 am EDT
article
Fact or Fantasy? The Promise Of A Genomics Health-Care Revolution
Imagine a future world in which we prevent disease before it develops, remove trial-and-error from t
reatment, and trust that our doctors have all the information they need to treat us as unique individuals. That is the promise of genomic medicine.,
An estimated 65 million human genomes are expected to be sequenced by 2025.
, Take, for example, a critically ill baby in intensive care where doctors are struggling to find a diagnosis.
+ Read More
video
Advances in Science: A Decade of Progress in Alzheimer’s Disease Research
Rajiv Ahuja, associate director at the Milken Institute, focusing on the future of aging, moderate
s this Advances in Science webinar with featured guest Richard J.
+ Read More